glp-1 and cancer risk Long-term in users of agonists in Denmark: a nationwide emulated trial OR | Early GLP-1 Agonist
Description
101 Albiglutide Albiglutide was approved by the FDA in 2014
Yammine, L
Therefore, the aim of this study was to examine the analgesic and anti-inflammatory properties of liraglutide in treating OA, using in vivo and in vitro experiments
The Ascletis platform Ascletis Pharma is a Hong Kong-listed (1672.HK) biotech focused on metabolic disease
Tirzepatide is a dual-action injectable medication originally designed to support blood sugar control
These drugs, acting as agonists of Glucagon-like Peptide-1 receptor (GLP-1R), are recognized for promoting insulin secretion, suppressing glucagon release, and delaying gastric emptying [1]
